Non surgical debridement
Active Definitive Contract Awarded Last action
- Contract number
- 75A50126C00002
- Awardee
-
Vericel Corporation UEI WHK8B1525XA7
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $34,880,933
Award facts
- Opportunity
-
- Presolicitation Notice - NonSurgical Debridement Pre-Solicitation · 75A50125R00007 · Posted Jun 27, 2025
- Contract value 18% obligated
-
- $34,880,933.00 Current, with exercised options
- $191,776,871.00 Potential, with all options
- Completion date 6% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6510 Surgical Dressing Materials
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Cambridge, MA 02139, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
Vericel Corporation, a Cambridge, Massachusetts-based medical technology company specializing in advanced cell therapy and tissue engineering, was awarded a definitive contract valued at approximately $192 million by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR/BARDA) for non-surgical debridement products. The contract, which carries a cost-plus-fixed-fee pricing structure with no set-aside designation, was awarded on April 1, 2026, and extends through March 31, 2036. This procurement supports BARDA's national emergency preparedness efforts by establishing a vendor-managed inventory of enzymatic debridement products designed to treat severe burn injuries and blast trauma wounds during mass casualty incidents.
Under this extended contract, Vericel will maintain a preparedness inventory of advanced debridement solutions that can be rapidly deployed during national emergencies, with monthly reporting requirements to BARDA. The products are intended to provide more selective removal of necrotic burned tissue earlier in patient care, thereby reducing resource burden and improving outcomes. This award builds upon BARDA's existing vendor-managed inventory arrangement using Project BioShield funding and represents a significant expansion of Vericel's federal healthcare portfolio, which has historically focused on orthopedic and reconstructive products supplied primarily to the Department of Veterans Affairs.
Quick answers
Who was awarded contract 75A50126C00002?
75A50126C00002 was awarded to Vericel Corporation by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on April 1, 2026.
How much is contract 75A50126C00002 worth?
The government has obligated $34,880,933 on 75A50126C00002. Its potential value, with all options, is $191,776,871.
Was contract 75A50126C00002 competed?
The extent of competition for 75A50126C00002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award